Abstract

Introduction: Hypertriglyceridemia is a frequent dyslipidemia in type 2 diabetes. We aimed to determine its prevalence, its typology, and its associated factors in newly type 2 diabetes patients in Ouagadougou. Material and Method: This cross-sectional, descriptive and analytic study has been performed from May 2015 to June 2016 in the Internal medicine department in Yalgado Ouedraogo teaching hospital, Ouagadougou. An accidental sample of newly type 2 diabetes outpatients, na?ve of antidiabetics therapy was studied. A 12-hour fasting triglyceridemia was performed; hypertriglyceridemia was defined for triglyceridemia > 1.5 g/L (1.7 mmol/L). Data were analyzed with Epi info 7.1.5.0. Proportions and means were compared respectively with Khi2 or Fisher’s test and Student’s test with a significance of p i.e. 35 (34%) men and 68 (66%) women were included. The sex ratio was 0.51 and the mean age 49.3 ± 10.1 years [limits: 24 and 70]. The mean value of triglyceridemia was 1.8 ± 1.7 mmol/L [limits: 0.5 and 14.9]. Hypertriglyceridemia was reported in 32 patients (31.1%): minor (11.30 mmol/L) in one (3.1%) patients. Hypertriglyceridemia’s phenotype was commonly integrated into a mixed dyslipidemia; it was often combined with a total cholesterolemia increase and a HDL cholesterolemia decrease. In bivariate analysis, hyperglycemia was associated with severe hyperglycemia (p = 0.006) and renal failure (p = 0.03). Conclusion: Hypertriglyceridemia in type 2 diabetes is frequent and often combined with other lipids disorders. It may need an optimal care.

Highlights

  • Hypertriglyceridemia is a frequent dyslipidemia in type 2 diabetes

  • Hypertriglyceridemia’s phenotype was commonly integrated into a mixed dyslipidemia; it was often combined with a total cholesterolemia increase and a HDL cholesterolemia decrease

  • Considered for a long time as a cardiovascular risk marker in combination with High-Density Lipoprotein cholesterol (HDL cholesterol) level and Low-Density Lipoprotein cholesterol (LDL cholesterol) particles size decrease, insulin resistance and weight gain, hypertriglyceridemia seem to be according to recent epidemiological data, an independent cardiovascular risk factor [3]

Read more

Summary

Introduction

Hypertriglyceridemia is a frequent dyslipidemia in type 2 diabetes. We aimed to determine its prevalence, its typology, and its associated factors in newly type 2 diabetes patients in Ouagadougou. Considered for a long time as a cardiovascular risk marker in combination with High-Density Lipoprotein cholesterol (HDL cholesterol) level and Low-Density Lipoprotein cholesterol (LDL cholesterol) particles size decrease, insulin resistance and weight gain, hypertriglyceridemia seem to be according to recent epidemiological data, an independent cardiovascular risk factor [3] It intervenes especially alongside other factors as a residual cardiovascular risk factor, i.e. the risk of cardiovascular events which persists in subjects despite an achievement of LDL cholesterol level, blood pressure and blood glucose targets [4]. In order to describe the spectrum of this lipid’s disorder in our diabetes patients, we have performed this study to determine the prevalence, the typology, and the factors associated with hypertriglyceridemia in a cohort of newly type 2 diabetes patients in Ouagadougou

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call